IFYCLOTIN-1-MIU
Description_Effects
IFYCLOTIN-1-MIU contains Colistimethate Sodium 1,000,000 I.U., a powerful antibiotic used for the treatment of severe bacterial infections, especially those caused by multidrug-resistant Gram-negative bacteria. It is commonly reserved for critical cases where other antibiotics may not be effective, such as hospital-acquired infections, ventilator-associated pneumonia, urinary tract infections, bloodstream infections, and intra-abdominal infections. Colistin works by disrupting the bacterial cell membrane, leading to the death of the bacteria. IFYCLOTIN-1-MIU is typically administered by injection under the supervision of a qualified healthcare professional, as its use requires careful dosing and monitoring—especially in patients with kidney impairment. This antibiotic is often used in intensive care settings and in patients with serious or life-threatening infections caused by resistant organisms like Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. While patients may begin to feel better soon after starting treatment, it is crucial to complete the full course of the medicine as prescribed. Stopping it early can lead to incomplete treatment and antibiotic resistance. Possible side effects include kidney toxicity, neurotoxicity, or allergic reactions, so regular monitoring is essential. When used appropriately, IFYCLOTIN-1-MIU plays a vital role in treating critical infections and preventing complications.
